# Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

> **NCT07701967** · PHASE4 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 28 (estimated)

## Conditions studied

- Nasal Polyps

## Interventions

- **BIOLOGICAL:** Depemokimab

## Key facts

- **NCT ID:** NCT07701967
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-06-28
- **Final completion:** 2028-06-13
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701967, "Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*